NHS Scotland has approved a one-time CRISPR gene therapy for severe sickle cell disease, offering durable reduction in ...

High probability of technical success in pivotal Phase 3 trial based on unmatched efficacy data for third-line non-small cell ...

The immune system remains seriously out-of-whack—in an inflammatory state of overactivation and impaired ...

Eye drop nanoparticles that shrink over time overcome the eye's natural defenses, delivering protein drugs to the retina and ...

The Michigan House has passed bipartisan legislation to ban student cell phone use during classroom instruction across all ...

NouvNeu004: Recently received I-III all-stage IND approval from the NMPA, making it the world's first cell therapy product for Multiple System Atrophy (MSA) and iRegene's third self-developed product ...

In a push to start the year off with a potential bipartisan win, the Republican-led Michigan House has revived a piece of ...

Topline results show that epcoritamab, a T-cell engaging bispecific antibody administered subcutaneously, demonstrated an improvement in PFS in patients receiving epcoritamab monotherapy (HR, 0.74; 95 ...

An immunotherapy kept multiple myeloma at bay for over 80 percent of patients in a three-year clinical trial, and the FDA ...

Experimental drug slashes triglycerides and remnant cholesterol in trial, potentially filling gap for patients with ...

Gene that drops early in pancreatic tumors linked to shorter survival at stage II. Findings could guide future treatment ...

Artist, inventor and anatomist Leonardo da Vinci was the definition of a Renaissance man — and scientists are aiming to ...